Monday, 3 October 2016

Medical Robotic Systems Market To Gain From Increased Usage In Laparoscopy And Special Education Applications Till 2022: Grand View Research, Inc.



Global medical robotic systems market revenue is expected to reach USD 17.89 billion by 2022, according to a new report by Grand View Research, Inc. Key drivers of this market include the increasing demand for robotic surgeries, constant improvement in healthcare infrastructure in emerging economies, improving reimbursement policies and increasing awareness levels amongst healthcare establishments, and practitioners.
According to data published by the U.S. FDA in 2012, approximately 450,000 robotic assisted surgeries were performed. The increase in prevalence of cancer, neurological disorders, spinal disorders, and prostate disorders are expected to further propel the demand for minimally invasive surgeries and consequently boost market growth.
Further key findings from the study suggest:
·         The introduction of new generation robotic systems integrated with advanced data recorders, remote navigation systems, HD microscopic cameras, data analytic systems, motion sensors; 3D-Imaging and robotic controlled catheters are further expected to boost demand over the forecast period
·         Surgical robots was the largest product segment at over 60.0% in 2014, owing to the increasing number of robotic surgeries performed and increase in patient acceptance pertaining to assisted minimally invasive surgeries.
·         Non medical hospital robotic systems are identified as the fastest growing product segment. Key factors accounting for this rapid growth include growing interest in telemedicine robots and cart robots which improve the automation in the hospital sector and also improve the patient care.
·         On the basis of application, laparoscopy enabled systems accounted for the largest revenue share at 80.0% in 2014. Increase in geriatric population and rise in the prevalence of neurological disorders such as brain tumors, strokes, and spinal disorders are some factors expected to drive segment growth over the forecast period.
·         In 2014, North America was the largest regional market with revenue share valued at over 40% owing to, the presence of advanced healthcare infrastructure, increasing demand for robot assisted surgeries, better reimbursement policies and the increasing geriatric population.
·         Asia Pacific market is the most lucrative in terms of future growth. The presence of high unmet medical needs, growth in public and private healthcare investment, improving reimbursement framework, and the increasing healthcare expenditure levels.
·         The global industry share is majorly dominated by companies such as Intuitive Surgical Inc., Mazor Robotics and Hansen.
·         Other players like Accuray, S.R.L, Health robotics Varian, Reninshaw Plc. have developed products and applications catering to certain niche areas to establish market domination.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the Medical Robotic Systems market on the basis of product, application and region:
Product Outlook (Revenue in USD Million, 2012 - 2020)
·         Surgical Robots
o    Orthopedic Surgical Robots
§  iBlock surgical system
§  Robodoc surgical system
§  Navio PFS surgical system
§  MAKO RIO surgical system
§  Stanmore Sculptor surgical system
o    Neurosurgical Robotic Systems
§  Pathfinder surgical system
§  NeuroMate surgical system
§  Renaissance surgical system
o    Laparoscopy Robotic Systems
§  FreeHand endoscope holder system
§  Da Vinci robotic surgery system
§  Telelap ALF-X surgical system
o    Steerable Robotic Catheters
·         Rehabilitation Robots
o    Assistive Robots
o    Prosthetics
o    Orthotics
o    Therapeutic Robots
o    Exoskeleton Robotic Systems
·         Noninvasive Radiosurgery Robots
o    TrueBeam STx radiosurgery system
o    CyberKnife robotic radiosurgery system
o    Gamma Knife Perfexion radiosurgery system
·         Hospital and Pharmacy Robots
o    Telemedicine Robots
o     I.V. Robots          
o    Pharmacy Robots
o    Cart transportation robots
·         Emergency response robotic systems
o    LS-1 robotic system
o    Auto Pulse Plus robotic system
Application Outlook (Revenue in USD Million, 2012 - 2020)
·         Neurology
·         Orthopedics robotic systems
·         Laparoscopy
·         Special Education
Regional Outlook (Revenue, USD Million, 2012 - 2022)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa
For press release of this report - http://www.grandviewresearch.com/press-release/medical-robotic-systems-market-analysis
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          

Sunday, 2 October 2016

Optical Coherence Tomography Market Size Worth $1.8 Billion By 2024: Grand View Research, Inc.



The global optical coherence tomography (OCT) market is expected to reach USD 1.8 billion by 2024, according to a new report by Grand View Research, Inc. Increasing incidences of ocular diseases coupled with rising technological advancement in diagnostics is expected to boost the market for OCT based imaging devices. Furthermore, rising applications in cardiology, dermatology, oncology and other diseases is anticipated to support market growth over the forecast period.
Improvement in the design of the devices along with utility of advanced software is expected to enhance the healthcare provider’s ability to accurately diagnose and manage chronic conditions. For instance, Optovue launched AngioVue Retina in June 2016, which is expected to provide ophthalmologist with a smooth integration of the optical coherence tomography angiography technology into the workflow.
Government support towards increased diagnostic rate is another vital impact rendering driver. For instance, the U.S. FDA have launched multiple programs to facilitate routine screening of geriatric patients, which forms a large portion of the target group. Availability of favorable reimbursement, is further expected to increase the diagnostic rate for conditions such as age-related macular degeneration, retinopathy, vitreomacular traction along with various other conditions.


Further key findings from the study suggest:
·         The time domain segment spearheaded the optical coherence tomography market in 2015, whereas, spatially encoded domain OCT is expected to witness lucrative growth over the forecast period. This is the most advanced technology and finds application across various domains, thereby actively contributing to the market growth over the forecast period.
·         Ophthalmology forms the largest application segment and is expected to lose market share over the forecast period owing to the introduction of other application and their lucrative growth trend. For instance, application of these devices for dermatology imaging is predicted to be on rise over the next few years. The ability of OCT imaging devices to non-invasively provide 3D images up to 2-3 mm depth with higher resolution than ultrasound is expected to be the driver of this growth.
·         Asia Pacific region is predicted to witness the fastest growth by 2024 and hold over 25.0% of the market share. Presence of growth opportunities in regions such as Korea, China, India, Malaysia and others countries of South Asia are anticipated to be the vital impact rendering drivers. Furthermore, expansion of competitors and establishment of manufacturing units in the region are also anticipated to support growth.
·         Few of the key players include, Carl Zeiss Meditec AG, Topcon Medical Systems Inc., Optovue, Michelson Diagnostics Ltd., Heidelberg Engineering GmbH, Novacam Technologies Inc., Agfa Healthcare and Thorlabs Inc.
·         Carl Zeiss is a prominent participant of the OCT industry with product portfolio varying for time domain to spatially encoded frequency domain based devices. Their product Cirrus HD-OCT 5000 launched in 2013, is highly popular among ophthalmic practice.
·         Furthermore, the players are also developing modified components for these devices in order to meet the specific needs of clients. For instance, Thorlabs in August 2016 released, a polarization-dependent isolator and super luminescent diode which can be further customized.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-imaging

Grand View Research has segmented the global OCT market on the basis of technology, type, application and region.
Global OCT Market by Technology, 2013 - 2024 (USD Million)
·         Time Domain OCT (TDOCT)
·         Frequency Domain OCT (FD-OCT)
·         Spatial Encoded Frequency Domain OCT
o    Fourier Domain OCT (FDOCT)
o    Others
Global OCT Market by Type, 2013 - 2024 (USD Million)
·         Catheter based OCT devices
·         Doppler OCT devices
·         Handheld OCT devices
·         Tabletop OCT devices
Global OCT Market by Application, 2013 - 2024 (USD Million)
·         Ophthalmology
·         Cardiovascular
·         Oncology
·         Dermatology
·         Others
OCT Market by Region, 2013 - 2024 (USD Million)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-optical-coherence-tomography-oct-market

Cervical Cancer Diagnostic Market To Exhibit Growth At 49.6% CAGR For Pap Testing Segment Till 2024: Grand View Research, Inc.



The global cervical cancer diagnostic market was valued at USD 7 billion in 2015 and is expected to reach a value of USD 12 billion by 2024, according to a new report by Grand View Research, Inc. The key driving factors include the rising prevalence of cervical cancer, evolving screening technology, and various programs that promote routine check up and screening. According to the data published by the WHO, in 2012, over 270,000 women died due to cervical cancer, majority of which were from the developing countries. It is one of the most common cancer type diagnosed in women. Some of the etiological factors are multiple sex partners, and changing lifestyle, such as drinking & smoking and increased stress levels.
Furthermore, favorable government initiatives and increasing number of awareness programs are further expected to promote the market growth in coming few years. The National Cervical Cancer Coalition, WHO, CDC, the U.S. Preventive Services Task Force, are working towards promoting the necessity for early screening of cervical cancer amongst mid aged women.
There is an increasing demand for technologically advanced diagnostic procedures that facilitate the early intervention of the disease. The industry players are focused on developing innovative technological solutions for accurate and efficient results. Advancement in screening techniques, such as use of biomarkers, is gaining importance. The upsurge in technological developments is anticipated to further drive industry growth.
On account of increasing adoption of Pap test, the number of deaths due to cervical cancer has declined significantly in past few years. It helps detect precancerous lesions at an early state and, thus, reduces the number of cervical cancer cases. The American Cancer Society stated that the cervical cancer cases in last 40 years in the U.S. have declined by more than 50%. Initially, the Pap test screening was carried out every year which lead to further unnecessary procedures. However, the American Cancer Society now recommends that women in the age group of 21 to 29 should undergo Pap test every 3 years.


Further Key Findings from the Study Suggest:
·         In 2015, the Pap testing segment held majority of the market share of 49.6%. The segment’s large share can be attributed to the high efficiency of the tests in early diagnosis. Also, the increasing awareness about the impact of early diagnosis contributed to its growth.
·         In 2015, North America was the leading regional market with a revenue share of 48.3%. The U.S. is a key market in North America. Growing incidence of cervical cancer coupled with initiatives undertaken by government agencies in the form of awareness programs pertaining to the early screening of the disease are key factors for the country’s large market share.
·         Asia Pacific is expected to witness lucrative growth over the forecast period growing at a CAGR of 9.6%. The various steps undertaken by governments of developing countries such as India, China, Philippines, and other in order to improve healthcare infrastructure and to improve access to healthcare facilities are amongst key factors attributing to region’s high growth. Also, high prevalence of cancer in developing nations and increasing consumer awareness levels drive the growth
·         This market is presently dominated by a few key participants such as Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Abbott Laboratories, OncoHealth Corp, Hologic, Inc., QIAGEN, Quest Diagnostics, Inc and Guided Therapeutics, Inc. The key players focus specially on developing innovative solutions for diagnosis. For instance, F. Hoffmann-La Roche Ltd., in 2014, launched automated CINtec PLUS cytology test that efficiently detects the presence of precancerous cells.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Cervical cancer diagnostic market by outsourcing services, application, end use, and region:
Test type outlook (Market revenue in USD Billion, 2013 - 2024)
·         Pap Testing
·         HPV Testing
·         Colposcopy
·         Cervical Biopsies
·         Cystoscopy
Regional outlook (Market revenue in USD Billion, 2013 - 2024)
·         North America
·         U.S.
·         Canada
·         Europe
·         UK
·         Germany
·         Asia Pacific
·         Japan
·         China
·         Latin America
·         Brazil
·         Mexico
·         Middle East and Africa
·         South Africa

For press release of this report - http://www.grandviewresearch.com/press-release/global-cervical-cancer-diagnostics-market